|
Oct 10
|
Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook
|
|
Oct 9
|
Fagron SA (ARSUF) Q2 2024 Earnings Call Highlights: Strong Growth and Upgraded Revenue Guidance
|
|
Oct 8
|
Disclosure of notification received from AOC Pharma S.à r.l.
|